←
Sam Bacharach245 posts
Sam Bacharach avatar

Sam Bacharach

@BacharachSam

Postdoc at @AmberAlhadeff Lab. @MonellSc @PennBPP. He/his. Formerly @UMMedneuro, @NIDAnews, @UVA. Behavioral neuroscientist interested in reward and motivation

◷ Joined May 2019▧ 6 Photos and videos
Sam Bacharach avatar
Sam Bacharach@BacharachSam·22 Jun 2023

I'm beyond excited to share the product of my dissertation, and the latest work of @CaluLab_Bmore, now published in @SfNJournals #JNeurosci It’s got Pavlovian behavior, opto, eCBs, photometry, and dopamine (which of course is doing something unexpected)! jneurosci.org/content/43/25/…

Mark Rossi avatar
⟳ Sam Bacharach retweeted
Mark Rossi@WhoIsMarkRossi·14 May 2025

Excited to share our newest paper led by @kuldeepshrivas3 out now in @NatureComms nature.com/articles/s41467-0… 1/

@markandermann.bsky.social avatar
⟳ Sam Bacharach retweeted
@markandermann.bsky.social@andermann_mark·7 Nov 2024

We found that in vivo peptide release and signaling gradually enhances the response of satiety-promoting hypothalamic neurons to each bite of food during a meal. These consequences of each bite take minutes to manifest, and could help explain why slow eating enhances satiety.

I am thrilled to share the published version of our study on how neuropeptide signals regulate feeding in the hypothalamus! We imaged endogenous peptide signals in subcellular compartments during behavior. Below is an updated summary: rdcu.be/dZlI3

Post attachment
bluesky @neurorinaman avatar
⟳ Sam Bacharach retweeted
bluesky @neurorinaman@LindaRinaman·1 Aug 2024

Be mindful about axon collateralization! We have changed some experimental strategies based on this discovery. Proud to have the cover image for this journal issue and also a “Featured Article” designation! Happy times. jneurosci.org/content/44/31/…

Monell Center avatar
⟳ Sam Bacharach retweeted
Monell Center@MonellSc·10 Jul 2024

Today in @Nature-- @MonellSc researchers, led by @AmberAlhadeff, share new findings that point towards a possible way to reduce adverse side effects of popular next-generation obesity medications like GLP1-based drugs, known as semaglutide and marketed as Ozempic® and Wegovy®

1:49
AmberAlhadeff avatar
⟳ Sam Bacharach retweeted
AmberAlhadeff@AmberAlhadeff·10 Jul 2024

Drugs like Ozempic are great for weight loss, but they make some people feel sick. We discovered that the brain circuits mediating the appetite suppression are distinct from those that mediate nausea – a finding that may be leveraged to develop more selective GLP1-based drugs.

Nature Neuroscience avatar
⟳ Sam Bacharach retweeted
Nature Neuroscience@NatureNeuro·9 Jul 2024

A feature-specific reward prediction error (RPE) model: individual VTA #dopamine neurons report RPEs for different aspects of an animal’s situation, explaining heterogeneity in DA signals @rachel_s_l @SagivYotam @nathanieldaw @IlanaWitten nature.com/articles/s41593-0…

Camilla Nord avatar
⟳ Sam Bacharach retweeted
Camilla Nord@camillalnord·21 Jun 2024

How can some people - like meditators and free divers - control their own heart rates?? An impossibly cool paper where the answer comes from training rats 🐀 to regulate their 🫀 Top-down brain circuits for operant bradycardia | Science science.org/doi/10.1126/scie…